Risk factor reduction in progression of angiographic coronary artery disease

Hoang M Lai1, Wilbert S Aronow, Anthony D Mercando

  • 1Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York, USA.

Insights

Progressive coronary artery disease (CAD) was observed in 59% of outpatients. Higher mean arterial pressure was linked to CAD progression, suggesting blood pressure and LDL-C control are crucial for managing coronary artery disease.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Preventive Cardiology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Understanding factors influencing CAD progression is vital for patient management.
  • Differentiating progressive from nonprogressive CAD in outpatients requires further investigation.

Purpose of the Study:

  • To compare characteristics of outpatients with progressive versus nonprogressive coronary artery disease (CAD).
  • To identify clinical factors associated with CAD progression in an outpatient cardiology setting.

Main Methods:

  • Retrospective chart review of outpatients with at least two coronary angiographies (≥ 1 year apart).
  • Progressive CAD defined by new CAD in previously disease-free vessels or new obstruction in previously non-obstructive vessels.
  • Analysis included coronary risk factors, comorbidities, cardiovascular events, medications, serum low-density lipoprotein cholesterol (LDL-C), and blood pressure.

Main Results:

  • 183 outpatients (mean age 71) were analyzed with a mean follow-up of 11 years.
  • 59% (108/183) exhibited progressive CAD over a mean of 58 months between angiographies.
  • Progressive CAD was associated with significantly higher mean arterial pressure (97±13 vs. 92±12 mm Hg; p<0.05).
  • Serum LDL-C was insignificantly higher in progressive CAD patients (94±40 vs. 81±34 mg/dl; p=0.09).
  • Medication use (statins, beta-blockers, ACE inhibitors/ARBs, aspirin) did not differ significantly between groups.

Conclusions:

  • Elevated mean arterial pressure is a significant factor in CAD progression among outpatients.
  • While not statistically significant, higher LDL-C levels trended with disease progression.
  • Optimizing blood pressure and LDL-C control, alongside medical therapy, may be key to slowing coronary artery disease progression.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...